Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Matthews

Showing results (241-250 of 293) with videos related to

Pageof 30
Sort By:
International Journal of Epidemiology|February 20, 2026
New-onset diabetes following SARS-CoV-2 infection in the Omicron era: a matched cohort studyJiahui Qian, Sandrine Stepien, Allen Cheng, et al.
Journal of the International AIDS Society|September 7, 2023
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT studyJoanne M Carson, Sebastiano Barbieri, Evan Cunningham, et al.
Hepatology (Baltimore, Md.)|January 18, 2013
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infectionJason Grebely, Jordan J Feld, Tanya Applegate, et al.
Health Science Reports|August 24, 2022
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohortSofia R Bartlett, Andrey Verich, Joanne Carson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting TreatmentsEthel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.
AIDS (London, England)|November 20, 2025
Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studiesKris Hage, Joanne Carson, Samira Hosseini-Hooshyar, et al.
Open Forum Infectious Diseases|September 29, 2025
Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START studyNila J Dharan, Shweta Sharma, Alejandro Arenas-Pinto, et al.
Open Forum Infectious Diseases|April 1, 2024
Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020Brendan L Harney, Rachel Sacks-Davis, Paul Agius, et al.
Pathogens (Basel, Switzerland)|October 27, 2023
Screening for Hepatitis C Virus Reinfection Using a Behaviour-Based Risk Score among Men Who Have Sex with Men with HIV: Results from a Case-Control Diagnostic Validation StudyKris Hage, Marita van de Kerkhof, Anders Boyd, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Pageof 30

Showing results (241-250 of 293) with videos related to

Sort By:
Pageof 30
International Journal of Epidemiology|February 20, 2026
New-onset diabetes following SARS-CoV-2 infection in the Omicron era: a matched cohort studyJiahui Qian, Sandrine Stepien, Allen Cheng, et al.
Journal of the International AIDS Society|September 7, 2023
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT studyJoanne M Carson, Sebastiano Barbieri, Evan Cunningham, et al.
Hepatology (Baltimore, Md.)|January 18, 2013
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infectionJason Grebely, Jordan J Feld, Tanya Applegate, et al.
Health Science Reports|August 24, 2022
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohortSofia R Bartlett, Andrey Verich, Joanne Carson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting TreatmentsEthel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.
AIDS (London, England)|November 20, 2025
Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studiesKris Hage, Joanne Carson, Samira Hosseini-Hooshyar, et al.
Open Forum Infectious Diseases|September 29, 2025
Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START studyNila J Dharan, Shweta Sharma, Alejandro Arenas-Pinto, et al.
Open Forum Infectious Diseases|April 1, 2024
Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020Brendan L Harney, Rachel Sacks-Davis, Paul Agius, et al.
Pathogens (Basel, Switzerland)|October 27, 2023
Screening for Hepatitis C Virus Reinfection Using a Behaviour-Based Risk Score among Men Who Have Sex with Men with HIV: Results from a Case-Control Diagnostic Validation StudyKris Hage, Marita van de Kerkhof, Anders Boyd, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Pageof 30